Literature DB >> 30310695

Key topics in pulmonary vascular diseases (assembly 13) from the European Respiratory Society 2018 Parisian Congress.

Sheila Ramjug1, Anton Vonk Noordegraaf2, Marion Delcroix3.   

Abstract

Entities:  

Year:  2018        PMID： 30310695      PMCID： PMC6174126          DOI： 10.21037/jtd.2018.09.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  32 in total

1.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2016-02

2.  Validation of two predictive models for survival in pulmonary arterial hypertension.

Authors:  Olivier Sitbon; Raymond L Benza; David B Badesch; Robyn J Barst; C Gregory Elliott; Virginie Gressin; Jean-Christophe Lemarié; Dave P Miller; Erwan Muros-Le Rouzic; Gérald Simonneau; Adaani E Frost; Harrison W Farber; Marc Humbert; Michael D McGoon
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

3.  Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension.

Authors:  Agnieszka Ciarka; Vi Doan; Sonia Velez-Roa; Robert Naeije; Philippe van de Borne
Journal:  Am J Respir Crit Care Med       Date:  2010-03-01       Impact factor: 21.405

4.  The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.

Authors:  N Nickel; H Golpon; M Greer; L Knudsen; K Olsson; V Westerkamp; T Welte; M M Hoeper
Journal:  Eur Respir J       Date:  2011-09-01       Impact factor: 16.671

5.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

Authors:  M Humbert; O Sitbon; A Yaïci; D Montani; D S O'Callaghan; X Jaïs; F Parent; L Savale; D Natali; S Günther; A Chaouat; F Chabot; J-F Cordier; G Habib; V Gressin; Z-C Jing; R Souza; G Simonneau
Journal:  Eur Respir J       Date:  2010-06-18       Impact factor: 16.671

7.  Derivation and validation of a prognostic model for pulmonary embolism.

Authors:  Drahomir Aujesky; D Scott Obrosky; Roslyn A Stone; Thomas E Auble; Arnaud Perrier; Jacques Cornuz; Pierre-Marie Roy; Michael J Fine
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

8.  Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis.

Authors:  Wan Chin Hsieh; Pavel Jansa; Wei Chun Huang; Matus Nižnanský; Mohamend Omara; Jaroslav Lindner
Journal:  J Thorac Cardiovasc Surg       Date:  2018-05-17       Impact factor: 5.209

Review 9.  Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.

Authors:  Antonio Gómez-Outes; Ana Isabel Terleira-Fernández; Ramón Lecumberri; M Luisa Suárez-Gea; Emilio Vargas-Castrillón
Journal:  Thromb Res       Date:  2014-07-06       Impact factor: 3.944

10.  Immediate Discharge and Home Treatment With Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned Analysis.

Authors:  Daren M Beam; Zachary P Kahler; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2015-06-25       Impact factor: 3.451
View more
  1 in total

1.  Erratum to key topics in pulmonary vascular diseases (assembly 13) from the European Respiratory Society 2018 Parisian Congress.

Authors: 
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.